Global Group Director – Health Economics and Payer Evidence, Respiratory & Immunology (R&I)

At AstraZeneca, we turn ideas into life-changing medicines. Working here means being bold, thinking big, and working together to make the impossible a reality. We are passionate about the potential of science to address the unmet needs of patients around the world. We commit to those areas where we believe we can change the course of medicine and bring innovative ideas to life. Respiratory & Immunology, part of AstraZeneca BioPharmaceuticals, is a key disease area and growth driver to the company.

AstraZeneca is a recognized leader in respiratory care, bringing over 50 years of expertise to the field and continuously growing its portfolio in immune-mediated diseases. We are committed to tackling the significant unmet needs associated with these chronic and often debilitating conditions. Our robust pipeline and broad portfolio include inhaled medicines, biologics, and innovative new modalities crafted to reach biologic targets that were previously considered out of reach.

As the Global Group Director – Health Economics and Payer Evidence (R&I), you will play a key role in shaping the value strategy and payer evidence generation for our industry leading Respiratory and Immunology portfolio at AstraZeneca.

Within the Global Market Access & Pricing (GMAP) function and reporting to the Global R&I Access Head, you will lead a high-performing team responsible for establishing and executing the Health Economics and Payer Evidence (HEPE) strategy. Your work will ensure that our innovative therapies deliver and demonstrate maximum value to payers, healthcare systems, and ultimately to patients across the world.

What You’ll Do

• Provide strategic leadership and vision to a world-class HEPE team focused on Respiratory and Immunology, setting clear direction for portfolio projects and maximising value in a dynamic, competitive market.

• Design, implement and oversee payer evidence strategies across the full product lifecycle, supporting pricing, market access, and reimbursement objectives from early development to post-launch.

• Drive the generation of health economic analyses, outcomes research, real-world evidence, and payer analytics for both pipeline and in-market products.

• Provide comprehensive guidance for clinical development and market access, integrating payer perspectives and evidence needs to optimize global and local market readiness.

• Represent HEPE strategy and insights to senior internal leadership, external payers, and global health technology assessment bodies.

• Lead, motivate, and develop a globally distributed team, driving a high-performance culture, professional growth, and effective prioritisation.

• Maintain expert knowledge in payer evidence methodology, value demonstration, and evolving scientific and healthcare system trends.

• Collaborate across Medical Affairs, RWE, Patient Reported Outcomes, Clinical Development, Regulatory, and Market Access to deliver integrated value evidence plans.

• Advance AstraZeneca’s reputation through external engagements with academic leaders, HTA bodies, and industry forums.

• Partner in launch planning, prepare payer evidence submissions, and support reimbursement negotiations globally.

• Contribute as a GMAP leadership team member, crafting AstraZeneca’s future access solutions for patients worldwide.

Minimum Qualifications

• Bachelor’s degree in a relevant field.

• 10 years’ experience in health economics, outcomes research, payer evidence, pricing, or market access, including project management in pharmaceutical, biotech, or healthcare settings.

• Demonstrated expertise in health economic modelling, outcomes research, real-world evidence generation, and payer analytics.

• Strong understanding of global healthcare systems, payer and HTA requirements, and evolving reimbursement landscapes across major markets.

• Proven ability to lead, encourage, and develop high-performing, diverse teams.

• Proven track record in planning, working with collaborators from various departments, and influencing senior internal and external collaborators.

Preferred Qualifications

• Master’s degree in outcomes research, health economics, epidemiology, health policy, health services research, or related field.

• Experience in respiratory and immunology therapeutic areas.

• Track record in developing payer/market access strategies delivering significant reimbursement outcomes.

• Established reputation inside and outside the industry as a thought leader in value demonstration.

• Experience in innovative analytical and evidence-generation methodologies.

• Ability to navigate ambiguity, simplify complexity, and prioritize in fast-changing environments.

Why AstraZeneca?

This position be based at our Cambridge, UK and Gothenburg, Sweden sites. When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our exceptional and bold world!

AstraZeneca offers an environment where you can thrive by working with new drugs, digital approaches, and ever-changing environments. Our pioneering value-based agreements and Innovative Value Strategy solutions lead the way in the industry. We are driven by our determination to ensure the value of our medicines is realized. Our dynamic environment encourages creativity in designing strategies and innovative access solutions. We thrive on co-creation and draw on diverse perspectives to overcome challenges. Join us to be part of a team that is passionate about making a meaningful impact on patient outcomes.

Ready to make a difference? Apply now to join our team!

Date Posted

17-Jul-2025

Closing Date

31-Jul-2025

Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements.